http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108290882-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-554 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 |
filingDate | 2016-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-108290882-B |
titleOfInvention | Crystalline forms of a 4-quinazolinamine derivative for the treatment of respiratory syncytial virus infection |
abstract | The present invention relates to the compound (I) (3-amino-oxetan-3-ylmethyl) - [2- (5, 5-dioxo-5, 6,7, 9-tetrahydro-5. lambda.6. thia-8-aza-benzocyclohepten-8-yl) -6-methyl-quinazolin-4-yl]-novel crystalline forms of amines, and pharmaceutical compositions containing the crystalline forms thereof disclosed herein, which are useful for the treatment or prevention of viral diseases or diseases caused by Respiratory Syncytial Virus (RSV) infection in patients associated with RSV infection. The invention also relates to compositions and uses of the title compounds of the invention in amorphous form. |
priorityDate | 2015-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.